Thesis, a NYC-based company that offers a customized approach to cognitive performance products based on their brain chemistry, closed on a Series A round totaling $8.4m. Backers included Unilever Ventures, Redo Ventures, Alive VC, Break Trail, NBA superstar Kevin Love and model Kate Bock. Previously the company raised $5.1m in an undisclosed seed round that [...]The post Thesis Raises $13.5M in Funding appeared first on FinSMEs.
Thesis is a New York-based nootropics company that formulates and commercializes personalized brain health supplements and cognitive performance products for individuals.